(Q51374462)

4 April 2018

title

Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. (English)

1 reference

4 April 2018

author name string

Marinella Tzanela

1

1 reference

4 April 2018

Dimitra A Vassiliadi

2

1 reference

4 April 2018

Nikolaos Gavalas

3

1 reference

4 April 2018

Andrea Szabo

4

1 reference

4 April 2018

Eleni Margelou

5

1 reference

4 April 2018

Athina Valatsou

6

1 reference

4 April 2018

Charalambos Vassilopoulos

7

1 reference

4 April 2018

publication date

1 July 2011

1 reference

4 April 2018

published in

Clinical Endocrinology

1 reference

4 April 2018

volume

75

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

96-102

1 reference

4 April 2018

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Risk factors for glucose intolerance in active acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Acromegaly: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Relationship between blood pressure and glucose tolerance in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

A consensus on criteria for cure of acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Criteria for cure of acromegaly: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

Mortality in Acromegaly: A Metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.03996.X

10.1111/J.1365-2265.2011.03996.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018